StanleyBartCohenMD

PubMed

• 14 citations
  Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial
  Josef S Smolen, Stanley Cohen, Hans-Peter Tony, Morton Scheinberg, Alan Kivitz, Andra Balanescu, Juan J. Gomez-Reino, Liyi Cen, Johann Poetzl, Tamas Shisha, Dmitrij Ko...> ;Rheumatology. 2021 Jan 5
• 16 citations
  Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheum...
  Stanley Cohen, Niklas Czeloth, Eric Lee, Piotr Adrian Klimiuk, Nuala Peter, Girish Jayadeva> ;Expert Opinion on Biological Therapy. 2019 Aug 6
• 17 citations
  Brief Report: Safety and Immunogenicity of Rituximab Biosimilar GP 2013 After Switch From Reference Rituximab in Patients With Active Rheumatoid Arthritis.
  Hans-Peter Tony, Klaus Krüger, Stanley Cohen, Hendrik Schulze-Koops, Alan Kivitz, Sławomir Jeka, Edit Vereckei, Liyi Cen, Laura Kring, Dmitrij Kollins> ;Arthritis Care & Research. 2019 Jan 1
• 19 citations
  Extension Study of PF-05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis.
  Stanley Cohen, Rubén Burgos-Vargas, Paul Emery, Bo Jin, Carol Cronenberger, María‐Dolores Vázquez‐Abad> ;Arthritis Care & Research. 2018 Nov 1
• 2 citations
  What Advice Current Pathology Chairs Seek From Former Chairs.
  David N. Bailey, Stanley Cohen, Avrum I. Gotlieb, Mary F. Lipscomb, Fred Sanfilippo> ;Academic Pathology. 2018 Oct 22
• 85 citations
  Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid a...
  Stanley Cohen, Alberto Alonso-Ruiz, Piotr Adrian Klimiuk, Eric Lee, Nuala Peter, Ivo Sonderegger, Deepak Assudani> ;Annals of the Rheumatic Diseases. 2018 Jun 1
• 31 citations
  The Science Behind Biosimilars: Entering a New Era of Biologic Therapy.
  S. Louis Bridges, Douglas W. White, Angus B Worthing, Ellen M. Gravallese, James R. O'Dell, Kamala Nola, Jonathan Kay, Stanley Cohen> ;Arthritis & Rheumatology. 2018 Mar 1
• 48 citations
  A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis
  Josef S Smolen, Stanley Cohen, Hans-Peter Tony, Morton Scheinberg, Alan Kivitz, Andra Balanescu, Juan J. Gomez-Reino, Liyi Cen, Peijuan Zhu, Tamas Shisha> ;Annals of the Rheumatic Diseases. 2017 Sep 1
• 29 citations
  Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled ...
  Daniel Burge, J Eisenman, Kelly Byrnes-Blake, P Smolak, K Lau, Stanley Cohen, Alan Kivitz, R Levin, Richard J. Martin, Y Sherrer, James Posada> ;Lupus. 2017 Jul 1
• 18 citations
  Biosimilars: implications for rheumatoid arthritis therapy.
  Stanley Cohen, Jonathan Kay> ;Current Opinion in Rheumatology. 2017 May 1
• 13 citations
  Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus
  John R. Doedens, Wendell D. Jones, Kay Hill, Michael Mason, Vivian H. Gersuk, Philip J. Mease, Maria Dall'Era, Cynthia Aranow, Richard J. Martin, Stanley Cohen, Roy Fl...> ;Journal of Immunology. 2016 Oct 1
• 55 citations
  Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
  Rieke Alten, Clifton O. Bingham, Stanley Cohen, Jeffrey R. Curtis, S. Kelly, D. Wong, Mark C. Genovese> ;BMC Musculoskeletal Disorders. 2016 May 26
• 37 citations
  Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.
  Stanley Cohen, Andrew S Koenig, Lisy Wang, Kenneth Kwok, Charles A Mebus, R. Riese, Roy Fleischmann> ;Clinical and Experimental Rheumatology. 2016 Jan 1
• 38 citations
  Efficacy and safety of tofacitinib in US and non-US rheumatoid arthritis patients: pooled analyses of phase II and III.
  Stanley Cohen, Andrew S Koenig, Lisy Wang, Kenneth Kwok, Charles A Mebus, R. Riese, Roy Fleischmann> ;Clinical and Experimental Rheumatology. 2016 Jan 1
• 4 citations
  A perspective on digital and computational pathology
  Bhagavathi Ramamurthy, Frederick D. Coffman, Stanley Cohen> ;Journal of Pathology Informatics. 2015 Jan 1
• 6 citations
  MIF inhibits monocytic movement through a non-canonical receptor and disruption of temporal Rho GTPase activities in U-937 cells.
  Crystal J. DiCosmo-Ponticello, Daniel Hoover, Frederick D. Coffman, Stanley Cohen, Marion C. Cohen> ;Cytokine. 2014 Sep 1
• The evolution of anatomic pathology
  Stanley Cohen, Frederick D. Coffman> ;Analytical Cellular Pathology. 2013 Jan 1
• 1 citations
  The evolution of anatomic pathology: new strategies and emerging trends.
  Stanley Cohen> ;Studies in Health Technology and Informatics. 2013 Jan 1
• 27 citations
  Engaging basic scientists in translational research: identifying opportunities, overcoming obstacles
  Jennifer A. Hobin, Anne M. Deschamps, Richard S. Bockman, Stanley Cohen, Paul C. Dechow, Charis Eng, William R. Galey, Marianna Morris, Sharma Prabhakar, Usha Raj, Pet...> ;Journal of Translational Medicine. 2012 Apr 13
• Quantitative morphologic aspects of pathology.
  Stanley Cohen> ;Analytical Cellular Pathology. 2011 Jan 1
• 128 citations
  Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
  Robin K. Dore, Stanley Cohen, Nancy E Lane, William R Palmer, William Shergy, L. Zhou, H. Wang, Wayne Tsuji, Richard Newmark> ;Annals of the Rheumatic Diseases. 2010 May 1
• 173 citations
  Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid art...
  Stanley Cohen, Tien-Tsai Cheng, Vishala Chindalore, Nemanja Damjanov, Ruben Burgos-Vargas, Patricia Delora, Kathleen Zimany, Helen Travers, John P. Caulfield> ;Arthritis and Rheumatism. 2009 Feb 1
• 67 citations
  Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: t...
  Patrick Garnero, William S. Aronstein, Stanley Cohen, Philip G. Conaghan, Gary A Cline, C. Christiansen, John F. Beary, Joan M Meyer, Clifton O. Bingham> ;Osteoarthritis and Cartilage. 2008 Jun 1
• 408 citations
  Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blin...
  Stanley Cohen, Robin K. Dore, Nancy E Lane, Peter A. Ory, Charles G. Peterfy, John T. Sharp, Désirée Van Der Heijde, L. Zhou, Wayne Tsuji, Richard Newmark> ;Arthritis and Rheumatism. 2008 May 1
• 143 citations
  Pharmacokinetics and safety of golimumab, a fully human anti-TNF-α monoclonal antibody, in subjects with rheumatoid arthritis
  Honghui Zhou, Haishan Jang, Roy Fleischmann, Esther Bouman-Thio, Zhenhua Xu, Joseph C. Marini, Charles Pendley, Qun Jiao, Gopi Shankar, Stanley J. Marciniak, Stanley C...> ;Journal of Clinical Pharmacology. 2007 Mar 1
• Join now to see all